Galanin receptor neurons express one or more of the three galanin receptor subtypes (GALR1, GALR2, GALR3), G protein-coupled receptors that bind the neuropeptide galanin. These neurons are widely distributed throughout the central and peripheral nervous systems and play diverse roles in modulating neurotransmission, neuroprotection, metabolism, and behavior.
| Property |
Value |
| Category |
Neuropeptide receptor neurons |
| Gene |
GALR1, GALR2, GALR3 |
| Receptor Type |
G protein-coupled receptor (GPCR) |
| Neurotransmitter |
Galanin (30 amino acid neuropeptide) |
| Primary Brain Regions |
Hypothalamus, hippocampus, amygdala, cortex, brainstem |
| Peripheral Sites |
Gut, pancreas, adrenal gland |
Galanin is a 30-amino acid neuropeptide:
- Discovery: First isolated in 1978 from porcine intestine
- Distribution: Widely expressed in CNS and PNS
- Processing: Derived from preprogalanin precursor
- Receptors: Binds to three receptor subtypes
Three galanin receptor genes exist:
GALR1 (GALR1):
- Chromosome 18q23
- Predominantly expressed in brain
- Coupled to Gi/o proteins
- Inhibits adenylate cyclase
GALR2 (GALR2):
- Chromosome 17q25.3
- Wide distribution
- Multiple signaling pathways
- Gi/o and Gq coupling
GALR3 (GALR3):
- Chromosome 22q13.1
- Lower expression levels
- Gi/o coupling
- Less studied
All galanin receptors are Class A GPCRs:
- Seven transmembrane domains
- N-terminal glycosylation
- Conserved DRY motif
- Multiple splice variants
¶ Anatomy and Distribution
Hypothalamus:
- Paraventricular nucleus (PVN)
- Arcuate nucleus (ARC)
- Supraoptic nucleus (SON)
- Lateral hypothalamus
Hippocampus:
- CA1-CA3 pyramidal layers
- Dentate gyrus granule cell layer
- Hilus/interneuron populations
Amygdala:
- Central nucleus
- Basolateral complex
- Cortical nuclei
Cerebral Cortex:
- Layer V pyramidal neurons
- Various interneuron subtypes
Brainstem:
- Dorsal raphe nucleus
- Locus coeruleus
- Nucleus of the solitary tract
- Periaqueductal gray
Spinal Cord:
- Dorsal horn (laminae I-II)
- Motor neurons (ventral horn)
- Enteric nervous system: Gut motility
- Pancreas: Insulin secretion
- Adrenal gland: Stress response
- Cardiovascular system: Blood flow
Galanin receptor activation triggers:
GALR1/GALR3 (Gi/o-coupled):
- Inhibition of adenylate cyclase
- Activation of inward-rectifier K+ channels
- Inhibition of voltage-gated Ca2+ channels
- MAPK activation
GALR2 (Gq/Gi-coupled):
- Phospholipase C activation
- IP3/DAG production
- Calcium release
- Multiple downstream effects
Galanin acts as a neuromodulator:
-
Inhibits neurotransmitter release
- Reduces glutamate release
- Decreases acetylcholine
- Modulates GABA
-
Postsynaptic effects
- Hyperpolarizes neurons
- Reduces firing rates
- Alters plasticity
-
Presynaptic modulation
- Reduces neurotransmitter release
- Acts as autoreceptor
- Heterosynaptic effects
Pain Modulation:
- Analgesic effects in spinal cord
- Modulates nociceptive transmission
- Involved in chronic pain states
Feeding and Metabolism:
- Inhibits food intake (hypothalamus)
- Reduces appetite
- Modulates energy balance
Neuroprotection:
- Promotes neuronal survival
- Reduces excitotoxicity
- Supports regeneration
Learning and Memory:
- Hippocampal memory processes
- Synaptic plasticity modulation
- Cognitive effects
Mood and Behavior:
- Anxiety-related behaviors
- Depression-like states
- Social interaction
Galanin system develops early:
- Embryonic: Expression in developing brain
- Perinatal: Significant increases
- Postnatal: Refinement of patterns
- Adult: Stable distribution
- Neuronal differentiation
- Axon pathfinding
- Synapse formation
- Circuit maturation
Galanin in AD:
- Galanin hyperinnervation: compensatory mechanism
- GALR2 upregulation: in hippocampus
- Cognitive effects: galanin impairs memory
- Neuroprotection: trophic support
- Therapeutic targeting: galanin antagonists
Research:
- Galanin increases in AD brain
- Modulates cholinergic neurons
- May accelerate cognitive decline
In PD:
- Nigrostriatal galanin: Altered expression
- Motor effects: Modulates basal ganglia
- Neuroprotection: Supports dopaminergic neurons
- L-DOPA dyskinesias: Role in dyskinesia development
- Therapeutic potential: galanin analogs
Galanin is anticonvulsant:
- Reduces seizure severity
- Modulates excitability
- Protects against excitotoxicity
- Therapeutic application: galanin agonists
In pain pathways:
- Analgesic effects: Spinal and supraspinal
- Inflammatory pain: Modulates responses
- Neuropathic pain: Altered expression
- Potential therapy: galanin agonists
¶ Depression and Anxiety
- Antidepressant-like effects: galanin in mood
- Anxiety modulation: regional effects
- Stress response: HPA axis involvement
- Therapeutic potential
- Feeding behavior: appetite suppression
- Energy expenditure: metabolic effects
- Diabetes: pancreatic galanin
- Obesity: potential target
Galanin receptor targeting:
Agonists:
- Galanin peptide analogs
- Small molecule agonists
- Selective for receptor subtypes
Antagonists:
- GALR1-selective antagonists
- GALR2-selective antagonists
- Pan-receptor antagonists
- Pain management: Galanin agonists for chronic pain
- Epilepsy: Anticonvulsant potential
- Metabolic disorders: Feeding regulation
- Mood disorders: Antidepressant effects
- Neuroprotection: Neurodegenerative diseases
- Sedation: CNS depression
- Weight loss: Appetite suppression
- Seizures: At high doses
- GI effects: Motility changes
- Receptor binding assays
- mRNA localization (in situ hybridization)
- Immunohistochemistry
- Electrophysiology
- Behavioral assays
- GALR1 knockout mice
- GALR2 knockout mice
- GALR3 knockout mice
- Transgenic models
- Viral manipulations
- Kask K, et al. Galanin receptors. CNS Drugs. 2001
- Mitsukawa K, et al. Galanin in CNS. Handb Exp Pharmacol. 2008
- Wynick D, et al. Galanin and galanin receptors. Postgad Med J. 2008
- Juric DM, et al. Galanin in pain. Prog Neuropsychopharmacol Biol Psychiatry. 2015
- Counts SE, et al. Galanin in Alzheimer's disease. Mol Interv. 2008
- Ma X, et al. Galanin in Parkinson's disease. J Neurosci. 2009
- Schneider ER, et al. Galanin and feeding behavior. Nat Neurosci. 2010
- Bartfai T, et al. Galanin receptors as drug targets. Curr Drug Targets CNS Neurol Disord. 2003
- Lu X, et al. Galanin in epilepsy. Epilepsia. 2010
- Hawes JJ, et al. Galanin and behavior. Brain Res. 2008